Ex-Utero Code Completion for Autism Spectrum Disorder: Parental Blood Profiles as Biological Codebooks and Informational Signalate Constraints

This paper addresses a missing middle layer in autism spectrum disorder research. The central question is not whether ASD has genetic, immune, metabolic, sensory, behavioral, or developmental components, but whether these components can be organized into a measurable process of social-sensory-symbolic code closure. The paper proposes that, in a biologically defined subset of ASD, the child should not be modeled as defective, unconscious, or in need of normalization. Instead, the child is modeled as a conscious developing system whose shared codes linking sensation, language, affect, social salience, meaning, and reciprocal interaction may not have fully stabilized into low-burden, generalizable mappings. The paper develops an information-theoretic research framework called Ex-Utero Code Completion for Autism Spectrum Disorder. In this framework, the womb is interpreted as the original code-forming biological niche, and postnatal support is reframed as the possibility of reconstructing selected missing code-forming constraints after birth under strict research conditions. The central conceptual contribution is the parental blood codebook. Parental blood is not proposed as a transfusion material, therapy, or clinical product. It is treated as a biologically matched reference field containing measurable family-specific immune, metabolic, endocrine, inflammatory, extracellular, protein, lipid, metabolite, and regulatory signal information. By comparing this parental codebook with the child’s measured developmental code-state, the paper defines a child-specific missing-code vector across six developmental axes: sensory discretization, caregiver-child loop closure, social-symbolic mapping fixation, thermodynamic support, functional meaning assignment, and integrated multi-axis code closure. The proposed PBIS concept is then defined as a hypothetical, characterized, non-cellular, safety-screened, codebook-constrained informational signalate designed to approximate that missing-code vector. It is explicitly not raw blood, direct plasma infusion, stem-cell therapy, generic exosome therapy, home preparation, or any unapproved intervention. The structural theorem of the paper is conditional: if a family-specific parent-derived signal library reconstructs the child’s missing-code vector better than unrelated, shuffled-label, random, and nonspecific biological controls, then a PBIS candidate becomes mathematically definable as a research object. The predicted mechanism is sequential rather than immediate. First, missing-code burden should decrease. Second, biological and informational dissipation should decrease. Third, parent-anchored basis selection should stabilize. Fourth, basis sharpness and dominant social-symbolic mode occupancy should increase. Only downstream of these changes should broader social-symbolic integration and functional improvement be interpreted as model-consistent. The framework therefore rejects endpoint-only claims and requires a time-ordered mechanism signature. The paper also defines an Ex-Utero Code Completion Niche, in which any candidate signalate would be only one component within a broader developmental scaffold involving parental anchoring, sensory stabilization, sleep and metabolic support, immune and autonomic monitoring, developmental feedback, standard ASD supports, longitudinal measurement, and strict stopping rules. Existing behavioral, educational, speech-language, occupational, sensory, medical, and parent-mediated supports are not replaced; they remain the practical environment in which code growth would have to occur. The empirical layer is deliberately framed as a staged research program rather than evidence of clinical efficacy. The manuscript proposes an Interpretive Verification Protocol using public and controlled-access data, family multi-omics, maternal and cord-blood signatures, immune and metabolic datasets, EEG, fMRI, eye-tracking, dyadic synchrony, ex vivo perturbation models, and negative-control batteries. Its key empirical question is whether parent-specific reconstruction outperforms unrelated and nonspecific controls, and whether the predicted sequence from code-burden reduction to dissipation reduction to basis stabilization to social-symbolic integration is observed. The simulation layer is model-internal and treated only as a coherence test, not as clinical proof. The safety architecture is central to the paper. Any future candidate must be cell-free, pathogen-free, endotoxin-free, coagulation-safe, immune-screened, batch-characterized, traceable, exposure-controlled, GMP-produced, tested ex vivo before any child-facing exposure, and evaluated only under physician-led, IRB-approved research protocols. The paper also incorporates a MAR-ASD boundary: maternal autoantibody-related ASD is treated as both a safety exclusion and a specificity test, requiring screening and depletion of known harmful autoantibody signals before any candidate can proceed. The final decision gate states that no clinical interpretation is permitted unless codebook measurability, ASD subgroup structure, parent specificity, ex vivo response, safety, temporal mechanism order, and independent replication all pass. The conclusion is that ASD research in the defined subgroup should not be modeled as correction of a defective child, but as stepwise support of incomplete social-sensory-symbolic code architecture through parental codebook diagnosis, investigational signalate design, and measurable consciousness-flow regrowth. The paper’s value lies not in claiming an autism treatment, but in proposing a falsifiable, safety-bounded, subgroup-specific research architecture for testing whether missing developmental code constraints can be measured and supported after birth.

Keywords: autism spectrum disorder, ex-utero code completion, parental blood codebook, PBIS, informational signalate, missing-code vector, social-sensory-symbolic code closure, developmental code architecture, parent-specific reconstruction, cone inclusion, interpretive verification protocol, ex vivo testing, preclinical safety, neurodevelopmental research, code-completion niche, ASD subgroups, biological codebook, information physics.